Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

Telomir Pharmaceuticals / Equity Bottom-Up

<ul><li>Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases.</li><li> The company announced preclinical test results that showed Telomir-1 prevented cellular aging in human progeria cell lines.</li><li> This is further evidence that Telomir-1 has the potential to be a game-changing treatment in diseases associated with aging.</li></ul>

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced preclinical test results that showed Telomir-1 prevented cellular aging in human progeria cell lines. This is further evidence that Telomir-1 has the potential to be a game-changing treatment in diseases associated with aging.

TELO: Prevention of Cellular Aging in Patients with Progeria Possible